Bortezomib-encapsulated dual responsive copolymeric nanoparticles for gallbladder cancer targeted therapy
Gallbladder cancer (GBC) is a rare but the most malignant type of biliary tract tumor. It is usually diagnosed at an advanced stage and conventional treatments are unsatisfactory. As a proteasome inhibitor, bortezomib (BTZ) exhibits excellent antitumor ability in GBC. However, the long-term treatmen...
Main Authors: | Chen, Mingyu, Juengpanich, Sarun, Li, Shijie, Topatana, Win, Lu, Ziyi, Zheng, Qiang, Cao, Jiasheng, Hu, Jiahao, Chan, Esther, Hou, Lidan, Chen, Jiang, Chen, Fang, Liu, Yu, Jiansirisomboon, Sukanda, Gu, Zhen, Tongpeng, Suparat, Cai, Xiujun |
---|---|
Other Authors: | School of Physical and Mathematical Sciences |
Format: | Journal Article |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/170940 |
Similar Items
-
Bortezomib‐Encapsulated Dual Responsive Copolymeric Nanoparticles for Gallbladder Cancer Targeted Therapy
by: Mingyu Chen, et al.
Published: (2022-03-01) -
Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder Cancer
by: Jiasheng Cao, et al.
Published: (2021-10-01) -
DNA damage response inhibition‐based combination therapies in cancer treatment: Recent advances and future directions
by: Tianen Chen, et al.
Published: (2022-03-01) -
Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth
by: Jiahao Hu, et al.
Published: (2022-07-01) -
Development and Validation of a Nomogram for Predicting Survival in Gallbladder Cancer Patients With Recurrence After Surgery
by: Mingyu Chen, et al.
Published: (2021-01-01)